| Identification | Back Directory | [Name]
Butanoic acid, 4-[[(1R)-2-[1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1,2,4,7-tetrahydro-2,4-dioxo-1'-[[5-(trifluoromethyl)-2-furanyl]methyl]spiro[furo[3,4-d]pyrimidine-5(3H),4'-piperidin]-3-yl]-1-phenylethyl]amino]- | [CAS]
1454272-94-6 | [Synonyms]
Butanoic acid, 4-[[(1R)-2-[1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1,2,4,7-tetrahydro-2,4-dioxo-1'-[[5-(trifluoromethyl)-2-furanyl]methyl]spiro[furo[3,4-d]pyrimidine-5(3H),4'-piperidin]-3-yl]-1-phenylethyl]amino]- | [Molecular Formula]
C36H35F7N4O6 | [MOL File]
1454272-94-6.mol | [Molecular Weight]
752.68 |
| Hazard Information | Back Directory | [Description]
Merigolix is a gonadotrophin releasing hormone (GnRH) antagonist. | [Uses]
Merigolix is a potent gonadotrophin releasing hormone (GnRH) antagonist[1]. | [References]
[1] WHO Drug Information. International Nonproprietary Names for Pharmaceutical. |
|
|